
Gland Pharma Shares Soar After Successful USFDA Inspection
Gland Pharma Shares Soar After Successful USFDA Inspection
Gland Pharma experienced a significant boost in its share price, witnessing a 6.4% surge following the announcement of a successful inspection by the United States Food and Drug Administration (USFDA) at its Pashamylaram facility in Hyderabad.
USFDA Inspection and EIR Acquisition
The USFDA conducted a pre-market inspection of the Pashamylaram facility, focusing on its adherence to Quality System/Current Good Manufacturing Practice regulations for medical devices. Following the inspection, Gland Pharma received the Establishment Inspection Report (EIR), marking the successful conclusion of the inspection process.
Robust Performance in the Stock Market
Post the announcement, Gland Pharma’s shares peaked at ₹1,817.15 on the BSE, a 6.37% increase. This surge was accompanied by a more than fourfold increase in trading volume on the exchange, reflecting the market’s positive response to the company’s regulatory success.
Global Presence and Product Portfolio
Gland Pharma, a major player in the injectables market, has a global presence in over 60 countries, including the US, Europe, and Canada. The company operates primarily on a business-to-business model, offering a diverse range of injectable products such as vials, ampoules, and pre-filled syringes.
Financial Performance and Recent Approvals
Despite a 19.56% year-on-year decline in its consolidated net profit for Q2 of FY 2023-24, Gland Pharma’s revenue showed a significant increase, reflecting a 31.52% growth from the previous year. The company also secured provisional approval from the USFDA for an injection intended for treating low blood pressure in adults. Shares of Gland Pharma closed 2.88% higher at ₹1,757 per share
Latest Posts
- All India 16th Gufran Memorial T20 Tournament To Begin Tonight at Sports Stadium Doda
June 3, 2026 | Breaking News, Doda, Jammu Kashmir - Accident in Doda; 5 Injured
June 2, 2026 | Breaking News, India, Jammu Kashmir - Russia Strikes Ukraine; 9 Killed, Dozens Injured
June 2, 2026 | Breaking News, World - Home Ministry Amends Immigration and Foreigners Rules, 2025
June 2, 2026 | Breaking News, India, World - Cockroach Janta Party Founder Abhijeet Dipke To Arrive in India on June 06, Arrest Could Be on the Cards Too
June 2, 2026 | Breaking News, India, Politics - Supreme Court Appreciates Trial Court’s Efforts in Expediting Evidence in High-Profile Murder Case in Jammu
June 1, 2026 | Breaking News, Courts & Law, Jammu Kashmir - Niobium Opens Developer Partner Program for The Fog, the First IaaS Purpose-Built for Fully Homomorphic Encryption
June 1, 2026 | Business, World - Justice Sanjeev Kumar Appointed Acting Chief Justice of Jammu Kashmir and Ladakh High Court
June 1, 2026 | Breaking News, Courts & Law, India, Jammu Kashmir - Five Judges Elevated to Supreme Court of India, Strength Totals to 37
June 1, 2026 | Breaking News, Courts & Law, India - United States Attacks Iranian Air Defence System on Goruk and Qeshm Island
June 1, 2026 | Breaking News, Politics, World